Drug Approval | October 06, 2025
New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
Subscribe To Our Newsletter & Stay Updated
